Scheduling the adjuvant endocrine therapy for early stage breast cancer

被引:2
|
作者
Kahruman, Sera [1 ]
Ulusal, Elif [1 ]
Butenko, Sergiy [1 ]
Hicks, Illya V. [2 ]
Diehl, Kathleen M. [3 ]
机构
[1] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA
[2] Rice Univ, Houston, TX 77005 USA
[3] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA
关键词
Breast cancer; Adjuvant endocrine therapy; Scheduling; Mathematical programming; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; OPTIMIZATION APPROACH; TAMOXIFEN THERAPY; CHEMOTHERAPY; LETROZOLE; EXEMESTANE; ARIMIDEX; MODEL;
D O I
10.1007/s10479-010-0741-y
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
Based on the data available through published trial results, we build a mixed integer nonlinear programming (MINLP) model in order to find an optimal treatment plan for a given HR+ early stage breast cancer patient who is postmenopausal. The objective is to maximize the disease-free survival percentage at the end of the treatment period subject to the constraints on the risk of contralateral breast cancer and the risks of several side effects, including endometrial cancer, thromboembolic events, cardiovascular diseases, bone fractures, hot flushes, and vaginal bleeding. The results of numerical experiments suggest the effectiveness of some of the schedules currently used in practice, as well as suggest some attractive alternative treatment plans.
引用
收藏
页码:683 / 705
页数:23
相关论文
共 50 条
  • [1] Scheduling the adjuvant endocrine therapy for early stage breast cancer
    Sera Kahruman
    Elif Ulusal
    Sergiy Butenko
    Illya V. Hicks
    Kathleen M. Diehl
    Annals of Operations Research, 2012, 196 : 683 - 705
  • [2] Adjuvant endocrine Therapy in early stage Breast Cancer
    Ruckhaberle, Eugen
    Salmen, Jessica
    Fehm, Tanja
    GYNAKOLOGE, 2018, 51 (11): : 972 - 979
  • [3] Role of adjuvant endocrine therapy in early-stage breast cancer
    Muss, HB
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 313 - 321
  • [4] Adjuvant endocrine therapy for early breast cancer
    Andreetta, Claudia
    Smith, Ian
    CANCER LETTERS, 2007, 251 (01) : 17 - 27
  • [5] Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer
    Schwartzberg, Lee S.
    Cobb, Patrick
    Senecal, Frank
    Henry, David
    Kulig, Kimary
    Walker, Mark S.
    Houts, Arthur C.
    Stepanski, Edward J.
    BREAST, 2009, 18 (02): : 78 - 83
  • [7] Selection of optimal adjuvant endocrine therapy for early-stage breast cancer
    Al-Hajj A.
    O'Regan R.
    Current Treatment Options in Oncology, 2006, 7 (2) : 153 - 165
  • [8] Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
    Irene E. G. van Hellemond
    Sandra M. E. Geurts
    Vivianne C. G. Tjan-Heijnen
    Current Treatment Options in Oncology, 2018, 19
  • [9] Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer
    Corter, Arden L.
    Broom, Reuben
    Porter, David
    Harvey, Vernon
    Findlay, Michael
    PSYCHO-ONCOLOGY, 2018, 27 (09) : 2096 - 2103
  • [10] Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
    van Hellemond, Irene E. G.
    Geurts, Sandra M. E.
    Tjan-Heijnen, Vivianne C. G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (05)